Roche Diagnostics has appointed Robert Yates to be the new head of Roche Applied Science, a position he will take over from Manfred Baier, who will be retiring from the company at the end of the year. Yates formerly was global head of business development and licensing at Roche Diagnostics.
Rosetta Genomics President and CEO Kenneth Berlin will leave his position on the company's board of directors. The move is an effort to remain in standing with the company's corporate governance and division of responsibility between the board and the president and CEO. The board has elected current board observer Brian Markison, former chairman and CEO of King Pharmaceuticals, to be fill the empty seat.
Pankaj Singhal, senior vice president of product development and manufacturing at GenMark Diagnostics, will leave the company, effective April 29, GenMark said last week. Singhal will be replaced by diagnostics industry executive Sue Pierce. Pierce spent 11 years at Ventana Medical Systems, now part of the Roche Group, and 14 years at Abbott Laboratories' Diagnostics Division.